PIMCO INCOME STRATEGY FD II (PFN)

US72201J1043

7.26  -0.05 (-0.68%)

Fundamental Rating

2

PFN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of PFN have multiple concerns. PFN does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

In the past year PFN was profitable.
PFN had a positive operating cash flow in the past year.
PFN had positive earnings in 4 of the past 5 years.
In the past 5 years PFN reported 4 times negative operating cash flow.

1.2 Ratios

The last Return On Invested Capital (6.41%) for PFN is above the 3 year average (5.27%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.19%
ROE 3.75%
ROIC 6.41%
ROA(3y)3.51%
ROA(5y)4.35%
ROE(3y)5.04%
ROE(5y)5.65%
ROIC(3y)5.27%
ROIC(5y)5.1%

1.3 Margins

In the last couple of years the Profit Margin of PFN has declined.
PFN's Operating Margin has been stable in the last couple of years.
In the last couple of years the Gross Margin of PFN has remained more or less at the same level.
Industry RankSector Rank
OM 80.49%
PM (TTM) 32.29%
GM 80.8%
OM growth 3Y-1.31%
OM growth 5Y-1.45%
PM growth 3Y-27.36%
PM growth 5Y-30.65%
GM growth 3Y-1.24%
GM growth 5Y-1.4%

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, PFN has more shares outstanding
The number of shares outstanding for PFN has been increased compared to 5 years ago.
PFN has a better debt/assets ratio than last year.

2.2 Solvency

PFN has an Altman-Z score of 2.96. This is not the best score and indicates that PFN is in the grey zone with still only limited risk for bankruptcy at the moment.
PFN has a debt to FCF ratio of 0.78. This is a very positive value and a sign of high solvency as it would only need 0.78 years to pay back of all of its debts.
A Debt/Equity ratio of 0.14 indicates that PFN is not too dependend on debt financing.
Although PFN does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.78
Altman-Z 2.96
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

PFN has a Current Ratio of 0.05. This is a bad value and indicates that PFN is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.05 indicates that PFN may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05

1

3. Growth

3.1 Past

PFN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -82.92%.
Measured over the past years, PFN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -30.79% on average per year.
Looking at the last year, PFN shows a quite strong growth in Revenue. The Revenue has grown by 12.17% in the last year.
PFN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.07% yearly.
EPS 1Y (TTM)-82.92%
EPS 3Y-28.27%
EPS 5Y-30.79%
EPS growth Q2Q-65.45%
Revenue 1Y (TTM)12.17%
Revenue growth 3Y8.23%
Revenue growth 5Y7.07%
Revenue growth Q2Q13.97%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 24.20 indicates a rather expensive valuation of PFN.
When comparing the Price/Earnings ratio of PFN to the average of the S&P500 Index (25.25), we can say PFN is valued inline with the index average.
Industry RankSector Rank
PE 24.2
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.04
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.03%, PFN is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.45, PFN pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.03%

5.2 History

PFN has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of PFN decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1

5.3 Sustainability

277.40% of the earnings are spent on dividend by PFN. This is not a sustainable payout ratio.
DP277.4%
EPS Next 2YN/A
EPS Next 3YN/A

PIMCO INCOME STRATEGY FD II

NYSE:PFN (4/24/2024, 7:22:29 PM)

7.26

-0.05 (-0.68%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap615.50M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 11.03%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 24.2
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.19%
ROE 3.75%
ROCE
ROIC
ROICexc
ROICexgc
OM 80.49%
PM (TTM) 32.29%
GM 80.8%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-82.92%
EPS 3Y-28.27%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.17%
Revenue growth 3Y8.23%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y